论文部分内容阅读
2.1.2 激素 重组激素的市场基本上是以下产品的竞争:治疗糖尿病的胰岛素(insulin)、治疗生长障碍的人体生长激素(hGH)和治疗妇女不育症的卵泡刺激激素(follile—stimulating hormone)。Humulin是一种重组胰岛素,1982年获得FDA批准。该产品由Genentech转让给Lilly,1999年销售额超过了10亿
2.1.2 Hormones The market for recombinant hormones is essentially the competition between insulin for the treatment of diabetes, growth hormone (hGH) for growth disorders and follile-stimulating hormone for the treatment of infertility in women, . Humulin is a recombinant insulin that received FDA approval in 1982. The product was transferred to Lilly by Genentech, which had sales of more than 1 billion in 1999